glp-1 gastrointestinal side effects Managing Related to Medications How to eat if you

Prather said

"If you're not as influenced by that, it becomes easier." In her 2025 book, "The Ozempic Revolution," Dr

conducted target trial emulations comparing dual GLP-1/GIP agonists to GLP-1 monotherapy in patients with type 2 diabetes, finding that dual agonists were linked to numerically lower risks of MALOs, although confidence intervals overlapped, suggesting that extended observation period and larger patient cohorts may be needed to definitively establish comparative effectiveness [61]

Their ability to improve metabolic health while exerting anti-inflammatory and immunomodulatory effects makes them uniquely interesting for autoimmune conditions

2022;10 doi: 10.3389/fcell.2022.950623